235 related articles for article (PubMed ID: 28716129)
1. Current knowledge on feline injection-site sarcoma treatment.
Zabielska-Koczywąs K; Wojtalewicz A; Lechowski R
Acta Vet Scand; 2017 Jul; 59(1):47. PubMed ID: 28716129
[TBL] [Abstract][Full Text] [Related]
2. CT angiography and MRI imaging features do not predict the tumor type and grade of feline injection site sarcoma.
Fleming K; Nemanic S; Löhr CV; Terry J; Milovancev M
Vet Radiol Ultrasound; 2019 Nov; 60(6):668-679. PubMed ID: 31515897
[TBL] [Abstract][Full Text] [Related]
3. Combination of bleomycin and cisplatin as adjuvant electrochemotherapy protocol for the treatment of incompletely excised feline injection-site sarcomas: A retrospective study.
Spugnini EP; Vincenzi B; Carocci F; Bonichi C; Menicagli F; Baldi A
Open Vet J; 2020 Oct; 10(3):267-271. PubMed ID: 33282697
[TBL] [Abstract][Full Text] [Related]
4. Feline injection-site sarcoma: past, present and future perspectives.
Martano M; Morello E; Buracco P
Vet J; 2011 May; 188(2):136-41. PubMed ID: 20510635
[TBL] [Abstract][Full Text] [Related]
5. Curative-intent radical en bloc resection using a minimum of a 3 cm margin in feline injection-site sarcomas: a retrospective analysis of 131 cases.
Müller N; Kessler M
J Feline Med Surg; 2018 Jun; 20(6):509-519. PubMed ID: 28696150
[TBL] [Abstract][Full Text] [Related]
6. Murine xenograft model demonstrates significant radio-sensitising effect of liposomal doxorubicin in a combination therapy for Feline Injection Site Sarcoma.
Petznek H; Kleiter M; Tichy A; Fuchs-Baumgartinger A; Hohenadl C
Res Vet Sci; 2014 Oct; 97(2):386-90. PubMed ID: 25104320
[TBL] [Abstract][Full Text] [Related]
7. Elucidating the transcriptional program of feline injection-site sarcoma using a cross-species mRNA-sequencing approach.
Wei Q; Ramsey SA; Larson MK; Berlow NE; Ochola D; Shiprack C; Kashyap A; Séguin B; Keller C; Löhr CV
BMC Cancer; 2019 Apr; 19(1):311. PubMed ID: 30947707
[TBL] [Abstract][Full Text] [Related]
8. Role of nuclear factor-kappa B in feline injection site sarcoma.
Hsueh CS; Wu CH; Shih CH; Yeh JL; Jeng CR; Pang VF; Chiou HY; Chang HW
BMC Vet Res; 2019 Oct; 15(1):365. PubMed ID: 31653220
[TBL] [Abstract][Full Text] [Related]
9. Feline Injection Site Sarcomas: Data from Switzerland 2009-2014.
Graf R; Guscetti F; Welle M; Meier D; Pospischil A
J Comp Pathol; 2018 Aug; 163():1-5. PubMed ID: 30213367
[TBL] [Abstract][Full Text] [Related]
10. Injection site-associated sarcoma in the cat: treatment recommendations and results to date.
Ladlow J
J Feline Med Surg; 2013 May; 15(5):409-18. PubMed ID: 23603504
[TBL] [Abstract][Full Text] [Related]
11. Prevention of Feline Injection-Site Sarcomas: Is There a Scientific Foundation for Vaccine Recommendations at This Time?
Kass PH
Vet Clin North Am Small Anim Pract; 2018 Mar; 48(2):301-306. PubMed ID: 29217316
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant and adjuvant chemotherapy combined with anatomical resection of feline injection-site sarcoma: results in 21 cats.
Bray J; Polton G
Vet Comp Oncol; 2016 Jun; 14(2):147-60. PubMed ID: 24502401
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological and morphological analysis of feline injection site sarcomas.
Kliczkowska K; Jankowska U; Jagielski D; Czopowicz M; Sapierzyński R
Pol J Vet Sci; 2015; 18(2):313-22. PubMed ID: 26172181
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin Conjugated to Glutathione Stabilized Gold Nanoparticles (Au-GSH-Dox) as an Effective Therapeutic Agent for Feline Injection-Site Sarcomas-Chick Embryo Chorioallantoic Membrane Study.
Zabielska-Koczywąs K; Dolka I; Król M; Żbikowski A; Lewandowski W; Mieczkowski J; Wójcik M; Lechowski R
Molecules; 2017 Feb; 22(2):. PubMed ID: 28208720
[TBL] [Abstract][Full Text] [Related]
15. Concomitant liposomal doxorubicin and daily palliative radiotherapy in advanced feline soft tissue sarcomas.
Kleiter M; Tichy A; Willmann M; Pagitz M; Wolfesberger B
Vet Radiol Ultrasound; 2010; 51(3):349-55. PubMed ID: 20469561
[TBL] [Abstract][Full Text] [Related]
16. Epidemiological and Pathological Characterization of Feline Injection Site Sarcomas in Southern Brazil.
Cecco BS; Henker LC; De Lorenzo C; Schwertz CI; Bianchi RM; da Costa FVA; Driemeier D; Pavarini SP; Sonne L
J Comp Pathol; 2019 Oct; 172():31-36. PubMed ID: 31690412
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of leukocyte counts and neutrophil-to-lymphocyte ratio as predictors of local recurrence of feline injection site sarcoma after curative intent surgery.
Chiti LE; Martano M; Ferrari R; Boracchi P; Giordano A; Grieco V; Buracco P; Iussich S; Giudice C; Miniscalco B; Zani DD; Proverbio D; Morello E; Stefanello D
Vet Comp Oncol; 2020 Mar; 18(1):105-116. PubMed ID: 31441996
[TBL] [Abstract][Full Text] [Related]
18. Surgery alone versus surgery and doxorubicin for the treatment of feline injection-site sarcomas: a report on 69 cases.
Martano M; Morello E; Ughetto M; Iussich S; Petterino C; Cascio P; Buracco P
Vet J; 2005 Jul; 170(1):84-90. PubMed ID: 15993791
[TBL] [Abstract][Full Text] [Related]
19. Proteasomes are not a target for doxorubicin in feline injection-site sarcoma.
Cerruti F; Martano M; Morello E; Buracco P; Cascio P
J Comp Pathol; 2010; 143(2-3):164-72. PubMed ID: 20427050
[TBL] [Abstract][Full Text] [Related]
20. Association between Degree of Anaplasia and Degree of Inflammation with the Expression of COX-2 in Feline Injection Site Sarcomas.
Santelices Iglesias OA; Wright C; Duchene AG; Risso MA; Risso P; Zanuzzi CN; Nishida F; Lavid A; Confente F; Díaz M; Portiansky EL; Gimeno EJ; Barbeito CG
J Comp Pathol; 2018 Nov; 165():45-51. PubMed ID: 30502795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
